LDV Capital
  • Home
  • Portfolio
  • Vision Events
  • Insights
  • News
  • Community
  • Blog
  • About
LDV Capital
  • Home /
  • Portfolio/
  • Vision Events/
  • Insights/
  • News/
  • Community/
  • Blog/
  • About/
LDV Capital

LDV Blog

LDV Capital
  • Home /
  • Portfolio/
  • Vision Events/
  • Insights/
  • News/
  • Community/
  • Blog/
  • About/
March 15, 2022

Visual Tech is Critical to the Future of Life Sciences

March 15, 2022/ Kat Lopez
Visual Tech is Critical to the Future of Life Sciences

In the lead-up to our 8th Annual LDV Vision Summit, Evan Nisselson had the privilege of chatting with Amy Kruse, General Partner of Prime Movers Lab. On March 23rd, she will take part in our panel discussion on investing trends in businesses powered by visual technologies.

Read More
March 15, 2022/ Kat Lopez/
Biotech & Life Sciences
Amy Kruse, Prime Movers Lab, life sciences investments, neuroscience, human augmentation, synthetic biology, longevity, regeneration, agriculture, Paradromics, Gilgamesh Pharmaceuticals, Cognixion, Iridia, IVIVA Medical, Attune Neurosciences, Optios, Cubic Global Defense, DARPA, performance-oriented neuroscience programs, Loomis Innovation Council, Singularity University, Cell and Structural Biology, University of Illinois Champaign-Urbana, NSF Graduate Fellowship, venture capital, investing, life sciences, visual tech, sensors, inputs, imaging, healthcare, omics, personalized medicine, AR, VR, digital therapies, mental health therapeutics, behavioral health interventions, neurotechnology, EEG, electroencephalography, eye tracking, AR interface, augmented cognition, accelerated learning, cognitive enhancement, team neurodynamics, brain stimulation, mental health

Stay In The Know

From New Materials to Biotech, Neuroscience and More: Your Monthly Dispatch on All Things Visual Tech & AI

Thank you!

©LDV Capital